ArticleFrontiers in plant science2025
An enhanced lightweight model for apple leaf disease detection in complex orchard environments.
Article in Frontiers in plant science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- MobileNet-WDD: a lightweight deep learning image classification method for identifying defects in wheat grains.Frontiers in plant science · 2026Article
- A Comprehensive Review of Deep Learning in Computer Vision for Monitoring Apple Tree Growth and Fruit Production.Sensors (Basel, Switzerland) · 2025Review
- LeafSightX: an explainable attention-enhanced CNN fusion model for apple leaf disease identification.Frontiers in artificial intelligence · 2025Article
- SRC-YOLOv8n: a lightweight framework for fine-grained apple leaf disease detection with spatial detail preservation and multi-scale feature enhancement.Frontiers in plant science · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Automated detection of apple leaf diseases is crucial for predicting and preventing losses and for enhancing apple yields. However, in complex natural environments, factors such as light variations, shading from branches and leaves, and overlapping disease spots often result in reduced accuracy in detecting apple diseases. To address the challenges of detecting small-target diseases on apple leaves in complex backgrounds and difficulty in mobile deployment, we propose an enhanced lightweight model, ELM-YOLOv8n.To mitigate the high consumption of computational resources in real-time deployment of existing models, we integrate the Fasternet Block into the C2f of the backbone network and neck network, effectively reducing the parameter count and the computational load of the model. In order to enhance the network's anti-interference ability in complex backgrounds and its capacity to differentiate between similar diseases, we incorporate an Efficient Multi-Scale Attention (EMA) within the deep structure of the network for in-depth feature extraction. Additionally, we design a detail-enhanced shared convolutional scaling detection head (DESCS-DH) to enable the model to effectively capture edge information of diseases and address issues such as poor performance in object detection across different scales. Finally, we employ the NWD loss function to replace the CIoU loss function, allowing the model to locate and identify small targets more accurately and further enhance its robustness, thereby facilitating rapid and precise identification of apple leaf diseases. Experimental results demonstrate ELM-YOLOv8n's effectiveness, achieving 94.0% of F1 value and 96.7% of mAP50 value-a significant improvement over YOLOv8n. Furthermore, the parameter count and computational load are reduced by 44.8% and 39.5%, respectively. The ELM-YOLOv8n model is better suited for deployment on mobile devices while maintaining high accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.